Format

Send to

Choose Destination
Eur J Ophthalmol. 2014 Jan-Feb;24(1):21-8. doi: 10.5301/ejo.5000330. Epub 2013 Jul 17.

Riboflavin/UVA photochemical therapy for severe infectious keratitis.

Author information

1
2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv - Israel.

Abstract

PURPOSE:

To describe the antibacterial activity of treatment with riboflavin and ultraviolet A light (UVA) in cases of severe infectious keratitis.

METHODS:

A retrospective analysis was performed of an interventional case series in which 6 eyes of 6 patients with severe infectious keratitis, all of whom were refractive to multidrug conventional therapy, were treated with riboflavin/UVA. The procedure was conducted according to the standardized protocol of corneal collagen crosslinking (CXL) for keratoconus. Best spectacle-corrected visual acuity and clinical outcomes were evaluated before and during the follow-up period.

RESULTS:

Five of the 6 patients showed rapid reduction in symptoms and decreased infiltrate size after riboflavin/UVA photochemical therapy. Signs of infection and inflammation mostly resolved within 1 to 2 weeks after the treatment. Despite this therapy, one patient continued to deteriorate, and penetrating keratoplasty was performed.

CONCLUSIONS:

The adjunctive use of riboflavin/UVA photochemical therapy has a positive effect on refractory infectious keratitis. The treatment seems to be safe and effective and should be considered as part of the first-line therapy in severe cases of infectious keratitis.

PMID:
23873492
DOI:
10.5301/ejo.5000330
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center